logo
Plus   Neg
Share
Email

FDA Approves Merck's SNDAs For PIFELTRO And DELSTRIGO - Quick Facts

Merck (MRK), known as MSD outside the U.S. and Canada, announced Friday that the U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications (sNDAs) for PIFELTRO (in combination with other antiretroviral agents) and DELSTRIGO (as a complete regimen) that expand their indications to include adult patients with HIV-1 infection.

These patients are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and no known substitutions associated with resistance to PIFELTRO or the individual components of DELSTRIGO.

The FDA's approval of the sNDAs was based on findings from DRIVE-SHIFT, the Phase 3 randomized, international, multicenter, open-label trial evaluating a switch to DELSTRIGO in virologically suppressed participants (HIV-1 RNA <50 copies/mL) on a baseline regimen for at least six months prior to trial entry with no history of virologic failure.

PIFELTRO (doravirine, 100 mg) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) to be administered in combination with other antiretroviral agents.

DELSTRIGO is a once-daily fixed-dose combination tablet of doravirine (100 mg), lamivudine (3TC, 300 mg) and tenofovir disoproxil fumarate (TDF, 300 mg).

DELSTRIGO and PIFELTRO do not cure HIV-1 infection or AIDS. Both were approved in the U.S. on August 30, 2018 for the treatment of HIV-1 infection in adults with no prior antiretroviral treatment history.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Tesla Motors Inc. (TSLA) surged 12% in extended trading session on Wednesday after the luxury electric car maker reported a surprise third-quarter profit, which trumped Wall Street estimates. Looking forward, the company said it is "highly confident" to exceed 360,000 deliveries this year. Palo... Spotify is offering free Google Home Mini speakers to all new and existing Spotify Premium users in the U.S. The music streaming service said Tuesday that the Google Home Mini offer is for all eligible Premium Individual and Premium Family master account users in the U.S. The offer is available through November 15, or until supplies last. Federal Cartridge recalled about 3,100 units of Blackhawk T-Series L2C gun holsters due to injury hazard, a statement published by the U.S. Consumer Product Safety Commission said. The safety switch on the firearm can change its position without the knowledge of the user due to the holster design, causing the gun to fire if the trigger is pulled and pose injury hazard to the user and bystander.
Follow RTT
>